This has been reversed with LY 294002, a PI3K inhibitor, or rapamycin, an mTOR inhibitor, in vitro and in vivo murine models; the latter was also associated with decreased tumor growth ([124,127]) (Figure 1). Here, MTOR is linked to neoplasm.